EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials

Lunbo Shi, Yan Zhao, Aihua Rao

African Health Sciences · 2023

DOI: 10.4314/ahs.v23i3.25 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift African Health Sciences, 2023. Verfasst von Lunbo Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of hematological oncology chemotherapy, Fenghua District People's Hospital of Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Disaccharides, Ferric Compounds, Ferrosoferric Oxide. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The efficacy of iron isomaltoside ferumoxytol versus iron sucrose to treat iron deficiency anemia remains controversial. We conduct this meta-analysis to explore the influence of iron isomaltoside ferumoxytol versus iron sucrose on iron deficiency anemia.

Methods

We have searched PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through March 2021 for randomized controlled trials (RCTs) assessing the effect of iron isomaltoside ferumoxytol versus iron sucrose on iron deficiency anemia. Meta-analysis was performed using the random-effect model.

Results

Four RCTs involving 3892 patients were included in the meta-analysis. Overall, compared with iron sucrose for iron deficiency anemia, iron isomaltoside showed similar change of Hb (SMD=0.14; 95% CI=-0.07 to 0.35; P=0.18), Hb responder (SMD=1.41; 95% CI=0.71 to 2.81; P=0.33), serum ferritin (SMD=15.13; 95% CI=-23.45 to 53.71; P=0.44), and transferrin saturation (SMD=1.20; 95% CI=-1.08 to 3.47; P=0.30). However, iron isomaltoside further improved serum-ferritin at week 2 than iron sucrose (SMD=204.79; 95% CI=38.23 to 371.35; P=0.02).

Conclusions

Iron isomaltoside ferumoxytol showed comparable efficacy to iron sucrose for the treatment of iron deficiency anemia. Keywords: Iron isomaltoside ferumoxytol; iron sucrose; iron deficiency anemia; randomized controlled trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyDisaccharidesFerric CompoundsFerrosoferric OxideHumansFerric Oxide, SaccharatedFerritinsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Iron isomaltoside ferumoxytoliron deficiency anemiairon sucroserandomized controlled trials

Substanzen

DisaccharidesFerric CompoundsFerric Oxide, SaccharatedFerritinsFerrosoferric Oxideiron isomaltoside 1000

Autor:innen und Institutionen

  • Department of hematological oncology chemotherapy, Fenghua District People's Hospital of Ningbo, Zhejiang, China.

Zitieren

APA

Shi, L., Zhao, Y., & Rao, A. (2023). Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials. African Health Sciences. https://doi.org/10.4314/ahs.v23i3.25

Vancouver

Shi L, Zhao Y, Rao A. Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials. African Health Sciences. 2023. doi:10.4314/ahs.v23i3.25

BibTeX
@article{Shi2023,
  author = {Shi, Lunbo and Zhao, Yan and Rao, Aihua},
  title = {Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials},
  journal = {African Health Sciences},
  year = {2023},
  doi = {10.4314/ahs.v23i3.25}
}
Kostenlos starten →